191 related articles for article (PubMed ID: 1838863)
1. Blood group H antigen in transitional carcinoma of the urinary bladder.
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
[TBL] [Abstract][Full Text] [Related]
2. [Expression of A,B and H blood group antigens in urothelial carcinoma of the urinary bladder].
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Cesk Patol; 1991 Mar; 27(1-2):13-9. PubMed ID: 1893425
[TBL] [Abstract][Full Text] [Related]
3. ABO blood groups and their relationship to transitional cell carcinoma of the urinary bladder in 30 Jordanian patients.
Murshidi MS
Acta Urol Belg; 1988; 56(4):517-22. PubMed ID: 3207084
[No Abstract] [Full Text] [Related]
4. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
Juhl BR
Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
[TBL] [Abstract][Full Text] [Related]
5. [Expression of the blood group antigens A and B in carcinoma of the urinary bladder].
Tichý M; Jansa P; Student V; Tichá V; Vanák J
Bratisl Lek Listy; 1992 Aug; 93(8):415-20. PubMed ID: 1464022
[TBL] [Abstract][Full Text] [Related]
6. Relationship of blood groups and transitional cell carcinoma of the bladder.
Kirkali Z; Eryigit M
Int Urol Nephrol; 1993; 25(3):255-7. PubMed ID: 8225826
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
[TBL] [Abstract][Full Text] [Related]
8. Altered cell surface antigen expression in bladder carcinoma detected by a new hemagglutinating monoclonal antibody.
Rearden A; Nachtsheim DA; Frisman DM; Chiu P; Elmajian DA; Baird SM
J Immunol; 1983 Dec; 131(6):3073-7. PubMed ID: 6417241
[TBL] [Abstract][Full Text] [Related]
9. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
Das G; Glashan RW
J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
[TBL] [Abstract][Full Text] [Related]
10. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder].
Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E
Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025
[TBL] [Abstract][Full Text] [Related]
11. Association of ABO (H) antigen negative transitional cell tumours with abnormal mucosal biopsies in superficial bladder cancer.
Das G
Arch Ital Urol Nefrol Androl; 1988 Sep; 60(3):295-9. PubMed ID: 2975863
[No Abstract] [Full Text] [Related]
12. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
Bkhatta AD; Makhlin NV
Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
[No Abstract] [Full Text] [Related]
13. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
Vallancien G; Rouger P; Leclerc JP; Kuss R
Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
[TBL] [Abstract][Full Text] [Related]
14. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
Summers JL; Coon JS; Ward RM; Falor WH; Miller AW; Weinstein RS
Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
[TBL] [Abstract][Full Text] [Related]
15. Deletion of ABH blood group isoantigen and prognosis in patients with transitional cell bladder carcinoma.
Malmström PU; Busch C; Norlen BJ
Scand J Urol Nephrol Suppl; 1988; 110():205-11. PubMed ID: 3187409
[No Abstract] [Full Text] [Related]
16. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
[TBL] [Abstract][Full Text] [Related]
17. Blood group ABO and Lewis antigens in bladder tumors: correlation between glycosyltransferase activity and antigen expression.
Orntoft TF; Wolf H
APMIS Suppl; 1988; 4():126-33. PubMed ID: 3146987
[TBL] [Abstract][Full Text] [Related]
18. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of the detection of ABO surface antigens by indirect immunofluorescence technic in transitional tumors of the bladder].
Borella T; Loro M; Dato I; Merlo F; Giudici M
Minerva Med; 1986 Sep; 77(34-35):1527-32. PubMed ID: 3531921
[TBL] [Abstract][Full Text] [Related]
20. CEA and ABO(H) in upper urinary tract transitional tumors.
Dalla Palma P; Parenti A; Poletti A
Appl Pathol; 1984; 2(3):146-52. PubMed ID: 6399981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]